Small Business Innovation Research (SBIR)
The Small Business Innovation Research (SBIR) program is a set-aside program (3.0% of an agency's extramural budget in FY2016) for domestic small business concerns to engage in Research/Research and Development (R/R&D) that has the potential for commercialization and public benefit. The SBIR program was established under the Small Business Innovation Development Act of 1982 (P.L. 97-219). In December of 2011, the program was re-authorized through FY2017 by the 2012 Defense Authorization Act (P.L.112-81).
CDC’S Small Business Innovation Research (SBIR) program functions to promote Research and Development (R&D) from small businesses, where innovation and innovators thrive, in order to effectively support the health promotion and disease prevention needs and goals of CDC.
Today, CDC’s SBIR program is under the stewardship of the Office of the Associate Director for Science, Office of Technology and Innovation (OTI). This office is committed to ensuring a competitive award process that results in projects of scientific excellence and technological innovation with the potential for commercialization.
About the SBIR Program
The SBIR Program was established by Congress in 1982 to provide increased opportunities for small businesses to participate in R&D, to increase employment, and to improve U.S. competitiveness.
The program's specific objectives are to:
- Use small businesses to stimulate technological innovation,
- Strengthen the role of small business in meeting Federal R/R&D needs,
- Increase private sector commercialization of innovations developed through Federal SBIR R&D,
- Increase small business participation in Federal R/R&D, and
- Foster and encourage participation by socially and economically disadvantaged small business concerns and women-owned business concerns in the SBIR program.
Only United States small business concerns (SBCs) are eligible to submit SBIR applications. A SBC is one that, on the date of award for both Phase I and Phase II funding agreements, meets ALL of the criteria as described in the current SBIR parent funding opportunity announcement available at the NIH Small Business Funding Opportunities website.
Three Phases of SBIR
Funding is awarded competitively and is available for only Phases I and II of the SBIR program:
- Phase I awards projects up to $150,000 for approximately 6 months to support exploration of the technical merit or feasibility of an idea or technology.
- Phase II awards projects that expand Phase I results. Awards are for up to $1,000,000 for a time period of up to 2 years. During this time, the R&D work is performed and the developer evaluates commercialization potential.
- Phase III is the period during which Phase II innovation moves from the laboratory into the marketplace. At this stage, the small business must find funding in the private sector or other non-SBIR funding.
CDC SBIR Funding Opportunities
CDC participates in the PHS 2016-1 SBIR Contract Solicitation and the SBIR Omnibus FOA (PA-15-269) Grant Solicitation with NIH. The receipt date for the CDC SBIR contract proposal is October 16, 2015. The receipt dates for the SBIR grant FOA are on September 5, 2015, January 5, 2016 and April 5, 2016. For the FY16 SBIR Grant Omnibus, CDC also encourages investigator-initiated applications that focus on support for Ebola Safety and Response with a focus on virus transmission, disease prevention and control, public health preparedness, and vaccine development. For more information concerning these current SBIR funding opportunities, please visit the following NIH website.
- The PHS 2016-1 SBIR Contract Solicitation has been amended!
New Submission Process: There is a new electronic submission process for all proposals. Applicants must use the Contract Proposal Submission (eCPS) website to submit their proposal. No other method of proposal submission is permitted. Instructions for electronic submission are provided in the solicitation.
The HHS SBIR Contract RFP Informational Webinar (PHS 2016-1) materials are now posted! Links to all webinar resources are provided below. The HHS SBIR Contract Solicitation and accompanying documents are also located on NIH SBIR Funding page.
- 17th Annual NIH SBIR/STTR Conference
Annual NIH SBIR/STTR Conference will be held in Seattle, Washington on October 27 – 29, 2015. Check out the agenda : The conference is broken into three tracks to meet the needs of varying levels of experience with SBIR/STTR: Track 1: Navigating through SBIR/STTR; Track 2: Circumventing the Hurdles, and Track 3: Path to Commercialization. The wide variety of topics offered make this conference ideal for SBIR/STTR newcomers, Phase I companies looking to advance to Phase II, and Phase II companies looking for commercial assistance, strategic partnership and investors.
SBIR Report Fraud, Waste and Abuse
The Office of Inspector General Hotline accepts tips from all sources about potential fraud, waste, abuse and mismanagement in Department of Health & Human Services programs. The reporting individual should indicate that the fraud, waste and/or abuse concerns an SBIR grant or contract, if relevant.
Visit the OIG Report Fraud website for additional information.
Please direct all inquiries to: Office of Technology and Innovation, email@example.com, 404-718-1386.